947661-79-2 Usage
General Description
4-[tert-butoxycarbonyl-[(4-methoxyphenyl)methyl]amino]butanoic acid is a chemical compound with potential applications in pharmaceutical and medicinal chemistry. It is a derivative of the amino acid butanoic acid, and its structure includes a tert-butoxycarbonyl group and a 4-methoxyphenylmethylamino group. 4-[tert-butoxycarbonyl-[(4-methoxyphenyl)methyl]amino]butanoic acid is of interest due to its potential as a drug precursor or intermediate, as well as its ability to modify the properties and functions of peptides. Its structure suggests that it may be used in the synthesis of peptide-based drugs or in the development of new therapeutic agents. Additionally, the presence of a methoxy group in its structure may confer unique pharmacological properties, making it a valuable chemical for further research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 947661-79-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,7,6,6 and 1 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 947661-79:
(8*9)+(7*4)+(6*7)+(5*6)+(4*6)+(3*1)+(2*7)+(1*9)=222
222 % 10 = 2
So 947661-79-2 is a valid CAS Registry Number.
947661-79-2Relevant articles and documents
Design and synthesis of novel pyrimido[4,5-b]azepine derivatives as HER2/EGFR dual inhibitors
Kawakita, Youichi,Seto, Masaki,Ohashi, Tomohiro,Tamura, Toshiya,Yusa, Tadashi,Miki, Hiroshi,Iwata, Hidehisa,Kamiguchi, Hidenori,Tanaka, Toshimasa,Sogabe, Satoshi,Ohta, Yoshikazu,Ishikawa, Tomoyasu
, p. 2250 - 2261 (2013/05/09)
A novel 7,6 fused bicyclic scaffold, pyrimido[4,5-b]azepine was designed to fit into the ATP binding site of the HER2/EGFR proteins. The synthesis of this scaffold was accomplished by an intramolecular Claisen-type condensation. As the results of optimiza
